Roy Schrijver
Publications by Year
Research Areas
Blood Coagulation and Thrombosis Mechanisms, Sepsis Diagnosis and Treatment, Neutrophil, Myeloperoxidase and Oxidative Mechanisms, Atherosclerosis and Cardiovascular Diseases, Immune Response and Inflammation
Most-Cited Works
- → Nonanticoagulant heparin prevents histone-mediated cytotoxicity in vitro and improves survival in sepsis(2013)289 cited
- → Targeting CD40-Induced TRAF6 Signaling in Macrophages Reduces Atherosclerosis(2018)190 cited
- → The Anticoagulant and Nonanticoagulant Properties of Heparin(2020)130 cited
- → Extracellular histone H3 levels are inversely correlated with antithrombin levels and platelet counts and are associated with mortality in sepsis patients(2015)95 cited
- → Discovery of Small Molecule CD40–TRAF6 Inhibitors(2015)94 cited
- → Rational design of small molecules targeting the C2 domain of coagulation factor VIII(2013)28 cited
- → Identification of novel small molecule inhibitors of activated protein C(2014)17 cited
- → Suppressive Role of Tissue Factor Pathway Inhibitor-α in Platelet-Dependent Fibrin Formation under Flow Is Restricted to Low Procoagulant Strength(2018)17 cited
- → Effects of Exogenous Recombinant APC in Mouse Models of Ischemia Reperfusion Injury and of Atherosclerosis(2014)10 cited
- → M6229 Protects against Extracellular-Histone-Induced Liver Injury, Kidney Dysfunction, and Mortality in a Rat Model of Acute Hyperinflammation(2024)8 cited